Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Free Cash Flow (2020 - 2025)

Vivos Therapeutics has reported Free Cash Flow over the past 6 years, most recently at -$5.3 million for Q4 2025.

  • Quarterly Free Cash Flow fell 72.72% to -$5.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$17.6 million through Dec 2025, down 32.68% year-over-year, with the annual reading at -$17.6 million for FY2025, 32.68% down from the prior year.
  • Free Cash Flow was -$5.3 million for Q4 2025 at Vivos Therapeutics, down from -$4.1 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$2.2 million in Q4 2021 and troughed at -$6.2 million in Q1 2022.
  • The 5-year median for Free Cash Flow is -$4.0 million (2025), against an average of -$4.0 million.
  • Year-over-year, Free Cash Flow plummeted 841.39% in 2021 and then surged 53.3% in 2023.
  • A 5-year view of Free Cash Flow shows it stood at -$2.2 million in 2021, then crashed by 44.27% to -$3.2 million in 2022, then increased by 15.62% to -$2.7 million in 2023, then decreased by 13.52% to -$3.1 million in 2024, then crashed by 72.72% to -$5.3 million in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Free Cash Flow are -$5.3 million (Q4 2025), -$4.1 million (Q3 2025), and -$4.3 million (Q2 2025).